Antioxidant Pathways in Alzheimer's Disease: Possibilities of Intervention

E-ISSN： 1873-4286|17|35|3861-3864

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.35, 2011-12, pp. : 3861-3864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is an effective immune intervention for Alzheimer's disease in prospect?

By Esiri M.M.

Trends in Pharmacological Sciences, Vol. 22, Iss. 1, 2001-01 ,pp. : 2-3

Elsevier

Access to resources Recommend Favorite

Metabolomics-based promising candidate biomarkers and pathways in Alzheimer's disease

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 5, 2015-01 ,pp. : 277-282

Govi-Verlag

Access to resources Recommend Favorite

Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease

Current Pharmaceutical Design, Vol. 22, Iss. 8, 2016-02 ,pp. : 1074-1085

Bentham Science Publishers

Access to resources Recommend Favorite

Ethnicity and Inflammatory Pathways - Implications for Vascular Disease, Vascular Risk and Therapeutic Intervention

Current Medicinal Chemistry, Vol. 14, Iss. 13, 2007-01 ,pp. : 1409-1425

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Cytokine Profile in Alzheimer's Disease Patients After Ingestion of an Antioxidant Beverage

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1233-1241

Bentham Science Publishers

Access to resources Recommend Favorite